|
1
|
Ball J, Carrington MJ, McMurray JJ and
Stewart S: Atrial fibrillation: Profile and burden of an evolving
epidemic in the 21st century. Int J Cardiol. 167:1807–1824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Alonso A and Bengtson LG: A rising tide:
The global epidemic of atrial fibrillation. Circulation.
129:829–830. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cappato R, Calkins H, Chen SA, Davies W,
Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, et al:
Updated worldwide survey on the methods, efficacy, and safety of
catheter ablation for human atrial fibrillation. Circ Arrhythm
Electrophysiol. 3:32–38. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morillo CA, Verma A, Connolly SJ, Kuck KH,
Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS and Natale A:
RAAFT-2 Investigators: Radiofrequency ablation vs antiarrhythmic
drugs as first-line treatment of paroxysmal atrial fibrillation
(RAAFT-2): A randomized trial. JAMA. 311:692–700. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gaita F, Caponi D, Pianelli M, Scaglione
M, Toso E, Cesarani F, Boffano C, Gandini G, Valentini MC, De Ponti
R, et al: Radiofrequency catheter ablation of atrial fibrillation:
A cause of silent thromboembolism? Magnetic resonance imaging
assessment of cerebral thromboembolism in patients undergoing
ablation of atrial fibrillation. Circulation. 122:1667–1673. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Phan K, Wang N, Pison L, Kumar N, Hitos K
and Thomas SP: Meta-analysis of dabigatran vs warfarin in patients
undergoing catheter ablation for atrial fibrillation. Int J
Cardiol. 189:199–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Di Biase L, Burkhardt JD, Santangeli P,
Mohanty P, Sanchez JE, Horton R, Gallinghouse GJ, Themistoclakis S,
Rossillo A, Lakkireddy D, et al: Periprocedural stroke and bleeding
complications in patients undergoing catheter ablation of atrial
fibrillation with different anticoagulation management: Results
from the role of coumadin in preventing thromboembolism in Atrial
Fibrillation (AF) patients undergoing catheter ablation (COMPARE)
randomized trial. Circulation. 129:2638–2644. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Douketis JD, Spyropoulos AC, Kaatz S,
Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK,
Kong DF, et al: Perioperative bridging anticoagulation in patients
with atrial fibrillation. N Engl J Med. 373:823–833. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
You JJ, Singer DE, Howard PA, Lane DA,
Eckman MH, Fang MC, Hylek EM, Schulman S, Go AS, Hughes M, et al:
Antithrombotic therapy for atrial fibrillation: antithrombotic
therapy and prevention of thrombosis, 9th ed: American college of
chest physicians evidence-based clinical practice guidelines.
Chest. 141:(Suppl 2). e531S–e575S. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Veen JJ and Makris M: Management of
peri-operative anti-thrombotic therapy. Anaesthesia. 70:(Suppl 1).
S58–S67. 2015. View Article : Google Scholar
|
|
11
|
Kim TH, Kim JY, Mun HS, Lee HY, Roh YH,
Uhm JS, Pak HN, Lee MH and Joung B: Heparin bridging in warfarin
anticoagulation therapy initiation could increase bleeding in
non-valvular atrial fibrillation patients: A multicenter
propensity-matched analysis. J Thromb Haemost. 13:182–190. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hori M, Connolly SJ, Zhu J, Liu LS, Lau
CP, Pais P, Xavier D, Kim SS, Omar R, Dans AL, et al: Dabigatran
versus warfarin: Effects on ischemic and hemorrhagic strokes and
bleeding in Asians and non-Asians with atrial fibrillation. Stroke.
44:1891–1896. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Crandall MA, Bradley DJ, Packer DL and
Asirvatham SJ: Contemporary management of atrial fibrillation:
Update on anticoagulation and invasive management strategies. Mayo
Clin Proc. 84:643–662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gage BF, Waterman AD, Shannon W, Boechler
M, Rich MW and Radford MJ: Validation of clinical classification
schemes for predicting stroke: Results from the National Registry
of Atrial Fibrillation. JAMA. 285:2864–2870. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeuthen EL, Lassen JF and Husted SE: Is
there a hypercoagulable phase during initiation of antithrombotic
therapy with oral anticoagulants in patients with atrial
fibrillation? Thromb Res. 109:241–246. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Baron TH, Kamath PS and McBane RD:
Management of antithrombotic therapy in patients undergoing
invasive procedures. N Engl J Med. 368:2113–2124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Douketis JD, Johnson JA and Turpie AG:
Low-molecular-weight heparin as bridging anticoagulation during
interruption of warfarin: Assessment of a standardized
periprocedural anticoagulation regimen. Arch Intern Med.
164:1319–1326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kovacs MJ, Kearon C, Rodger M, Anderson
DR, Turpie AG, Bates SM, Desjardins L, Douketis J, Kahn SR,
Solymoss S and Wells PS: Single-arm study of bridging therapy with
low-molecular-weight heparin for patients at risk of arterial
embolism who require temporary interruption of warfarin.
Circulation. 110:1658–1663. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
BRIDGE Study Investigators: Bridging
anticoagulation: Is it needed when warfarin is interrupted around
the time of a surgery or procedure? Circulation. 125:e496–e498.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Patel JP and Arya R: The current status of
bridging anticoagulation. Br J Haematol. 164:619–629. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Douketis JD, Spyropoulos AC, Spencer FA,
Mayr M, Jaffer AK, Eckman MH, Dunn AS and Kunz R: American College
of Chest Physicians: Perioperative management of antithrombotic
therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th
ed: American College of Chest Physicians Evidence-Based Clinical
Practice Guidelines. Chest. 141:(2 Suppl). e326S–e350S. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Steinberg BA, Peterson ED, Kim S, Thomas
L, Gersh BJ, Fonarow GC, Kowey PR, Mahaffey KW, Sherwood MW, Chang
P, et al: Use and outcomes associated with bridging during
anticoagulation interruptions in patients with atrial fibrillation:
Findings from the Outcomes Registry for Better Informed Treatment
of Atrial Fibrillation (ORBIT-AF). Circulation. 131:488–494. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Siegal D, Yudin J, Kaatz S, Douketis JD,
Lim W and Spyropoulos AC: Periprocedural heparin bridging in
patients receiving vitamin K antagonists: Systematic review and
meta-analysis of bleeding and thromboembolic rates. Circulation.
126:1630–1639. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Douketis JD, Healey JS, Brueckmann M,
Eikelboom JW, Ezekowitz MD, Fraessdorf M, Noack H, Oldgren J,
Reilly P, Spyropoulos AC, et al: Perioperative bridging
anticoagulation during dabigatran or warfarin interruption among
patients who had an elective surgery or procedure. Substudy of the
RE-LY trial. Thromb Haemost. 113:625–632. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sabir I, Khavandi K, Brownrigg J and Camm
AJ: Oral anticoagulants for Asian patients with atrial
fibrillation. Nat Rev Cardiol. 11:290–303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eikelboom JW and Hart RG: Intensity and
quality of warfarin anticoagulation in chinese patients: Setting
the record straight. Stroke. 46:5–6. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hussein AA, Martin DO, Saliba W, Patel D,
Karim S, Batal O, Banna M, Williams-Andrews M, Sherman M, Kanj M,
et al: Radiofrequency ablation of atrial fibrillation under
therapeutic international normalized ratio: A safe and efficacious
periprocedural anticoagulation strategy. Heart Rhythm. 6:1425–1429.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wazni OM, Heheiry S, Fahmy T, Barrett C,
Hoa S, Patel D, Di Biase L, Martin DO, Kanj M, Arruda M, et al:
Atrial fibrillation ablation in patients with therapeutic
international normalized ratio: Comparison of strategies of
anticoagulation management in the periprocedural period.
Circulation. 116:2531–2534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nam D, Sadhu A, Hirsh J, Keeney JA, Nunley
RM and Barrack RL: The use of warfarin for DVT prophylaxis
following hip and knee arthroplasty: How often are patients within
their target INR range? J Arthroplasty. 30:315–319. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arshad A, Johnson CK, Mittal S, Buch E,
Hamam I, Tran T, Shaw RE, Musat D, Preminger M, Sichrovsky T, et
al: Comparative safety of periablation anticoagulation strategies
for atrial fibrillation: Data from a large multicenter study.
Pacing Clin Electrophysiol. 37:665–673. 2014. View Article : Google Scholar : PubMed/NCBI
|
